email  |  print

Kevin E. Noonan, Ph.D. photo

312.913.2145 direct
noonan@mbhb.com
download v-card

300 South Wacker Drive
Chicago, IL  60606
312.913.0001 phone
312.913.0002 fax

practices

industries

Kevin E. Noonan, Ph.D.

Kevin E. Noonan has extensive experience in biotechnology and the chemical arts. Dr. Noonan brings more than 10 years of experience as a molecular biologist working on high-technology problems to his legal work. He has wide experience in all aspects of patent prosecution, interference, litigation, and client counseling on validity, infringement, and patenting strategy matters. He represents pharmaceutical and biotechnology companies both large and small, and he is particularly experienced in representing university clients in both patent prosecution and licensing to outside investors.

education

J.D., The John Marshall Law School, Cum Laude

Ph.D., Princeton University, Molecular Biology

Thesis: Genetic analysis of oncogenesis in mammalian cells

National Cancer Institute

  • Postdoctoral Fellowship

B.S., State University of New York

bar admissions

Illinois

Massachusetts

U.S. Court of Appeals for the Federal Circuit

U.S. Court of Appeals for the Seventh Circuit

U.S. District Court for the Northern District of Illinois

U.S. Patent & Trademark Office

honors & awards

"Best Lawyers in America" Publication

professional leadership

DePaul University College of Law

  • Adjunct Professor, Biotechnology Patent Law

The John Marshall Law School

  • Adjunct Professor

publications

Founding author of the Patent Docs weblog, a site focusing on biotechnology and pharmaceutical patent law.

"Revisiting the Patent Eligibility of Genes" snippets, Vol. 7, Issue 4, Fall 2009.

"Worldwatch Intellectual Property: Gene Patenting" Financier Worldwide, October 2009.

"Worldwide Pharmaceutical Drug Pricing and Patent Rights: A Recipe for Disaster?" Financier Worldwide, September 2009.

"Gene Patenting after In re Kubin: The Sky is Not Falling" snippets, Vol. 7, Issue 2, Spring 2009.

"Follow-on Biologic Drugs and Patent Law: A Potential Disconnect?" snippets, Vol. 6, Issue 1, May 2008.

"USPTO Patent Prosecution Practice Rule Changes" snippets, Vol. 4, Issue 1, September 2006.

"The Continued Confusion Over Written Description" snippets, Vol. 3, Issue 1, March 2005.

"Tools of the Trade: Scope of the Section 271(e)(1) Research Exemption" snippets, Vol. 1, Issue 2, Fall 2003.